BIOREM Inc.
BRM.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -25.83% | 165.70% | 67.45% | 87.33% | 11.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.83% | 165.70% | 67.45% | 87.33% | 11.62% |
| Cost of Revenue | -3.83% | 144.65% | 66.55% | 36.01% | 11.13% |
| Gross Profit | -64.77% | 219.78% | 70.63% | 1,426.13% | 12.49% |
| SG&A Expenses | -7.31% | 147.62% | 32.85% | 30.95% | -45.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.93% | 144.97% | 59.96% | 35.19% | -3.82% |
| Operating Income | -89.20% | 297.32% | 340.66% | 169.80% | 117.37% |
| Income Before Tax | -92.21% | 328.51% | 445.85% | 161.92% | 136.56% |
| Income Tax Expenses | -89.90% | 328.62% | 445.56% | 161.95% | 39.88% |
| Earnings from Continuing Operations | -92.87% | 328.47% | 445.82% | 161.91% | 194.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -92.87% | 328.47% | 445.82% | 161.91% | 194.64% |
| EBIT | -89.20% | 297.32% | 340.66% | 169.80% | 117.37% |
| EBITDA | -86.98% | 295.77% | 240.68% | 187.93% | 113.36% |
| EPS Basic | -92.81% | 325.52% | 443.48% | 161.98% | 188.56% |
| Normalized Basic EPS | -92.19% | 326.11% | 446.15% | 161.71% | 131.65% |
| EPS Diluted | -117.34% | 286.16% | 386.96% | 153.01% | 182.40% |
| Normalized Diluted EPS | -91.64% | 302.75% | 392.31% | 153.60% | 173.74% |
| Average Basic Shares Outstanding | -0.64% | 0.65% | 0.00% | 0.00% | 2.02% |
| Average Diluted Shares Outstanding | -7.26% | 6.52% | 18.01% | 15.37% | -13.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |